Data (PCA data) are available from the Harvard Dataverse (doi:[10.7910/DVN/1Y8YAI](http://dx.doi.org/10.7910/DVN/1Y8YAI)).

Introduction {#sec005}
============

Postoperative pain management is a clinical challenge. Inadequate pain relief after operation is associated with decreased patient satisfaction \[[@pone.0171275.ref001]\], delayed hospital discharge \[[@pone.0171275.ref002]\], adverse functional outcome \[[@pone.0171275.ref003]\], and increased morbidity and mortality \[[@pone.0171275.ref004]\]. Despite the advancement in our understanding of pathophysiology of nociception and development of novel analgesic techniques, opioids are still among the most commonly prescribed medications to treat moderate to severe postoperative pain. Although opioids are effective in relieving postoperative pain, there are great variations in opioid requirement to achieve adequate pain control among individual patient \[[@pone.0171275.ref005]--[@pone.0171275.ref009]\], and postoperative opioids is an major predictor of postoperative nausea and/or vomiting (PONV) \[[@pone.0171275.ref010]--[@pone.0171275.ref014]\]. Although PONV rarely leads to serious complications, it may decrease patient satisfaction and increase healthcare cost \[[@pone.0171275.ref011], [@pone.0171275.ref014]\]. Hence, knowledge regarding predicting factors of postoperative opioid requirement and of occurrence of opioid-related side effects such as PONV could be helpful in formulating an effective pain control program with minimized side effects for individual patient. Previous studies have examined numerous potential factors and identified age, types of surgery, pre-existing psychological distress, ethnicity, and genetic polymorphisms as predictors of opioid requirement after operation \[[@pone.0171275.ref005]--[@pone.0171275.ref009]\]. However, the literatures are insufficient in evaluating the impact of alcohol consumption on opioid consumption for pain control after a major operation. Similarly, early studies have examined numerous potential factors and identified age, gender, current smoking status, history of motion sickness or PONV, using volatile anesthetics and postoperative opioids as predictors of PONV \[[@pone.0171275.ref011]--[@pone.0171275.ref014]\], but there is only limited evaluation on the impact of alcohol consumption on the occurrence of PONV \[[@pone.0171275.ref010]\].

In fact, alcohol is one of the most commonly used substances around the world and is capable of exerting a multitude of impacts on pain perception and analgesic requirement. For example, chronic alcohol consumption can induce neuropathic pain through both central and peripheral mechanisms \[[@pone.0171275.ref015], [@pone.0171275.ref016]\]. In preclinical studies, acute administration of alcohol in animals can produce a moderate antinociceptive effect through interaction with the opioid receptor system in the central nervous system \[[@pone.0171275.ref017]--[@pone.0171275.ref019]\]. On the contrary, chronic alcohol consumption produced mechanical hyperalgesia and tolerance to opioid-induced antinociception in animal experiments \[[@pone.0171275.ref020], [@pone.0171275.ref021]\]. Clinically, it is perceived that patients with a history of frequent alcohol consumption require more opioids for postoperative pain control and experience less opioid-related side effects, such as nausea and vomiting than those without such a history. However, the clinical impact of chronic alcohol consumption on postoperative opioid consumption and occurrence of opioid-related side effects has been rarely addressed in previous studies \[[@pone.0171275.ref010]\]. The aim of this study was to evaluate whether frequent alcohol intake, in addition to other factors, is associated with an increased opioid requirement for postoperative pain control. Any association was also sought between frequent alcohol drinking and postoperative nausea and vomiting (PONV), because the occurrence of PONV has been attributed to postoperative administration of opioids \[[@pone.0171275.ref011]--[@pone.0171275.ref014]\].

Materials and methods {#sec006}
=====================

After approval by the institutional review board (IRB) of Chang Gung Memorial hospital (approval number: 102-3855B), a retrospective analysis of patients using intravenous patient-controlled analgesia (ivPCA) for postoperative pain control in a single tertiary center between January 2010 and September 2013 was conducted. Informed consent was not required by the IRB, because the data were analyzed anonymously. As literature has demonstrated a positive correlation between abdominal surgery and postoperative analgesic consumption \[[@pone.0171275.ref006]\], only patients receiving abdominal surgery were included in the analysis. Those who received laparoscopic abdominal surgery, non-abdominal surgery, another operation within one week, partial agonists or antagonists of opioid receptors were excluded from the study. Patients who used opioid chronically or with incomplete data were also excluded from the study.

As the routine practice in our department, major abdominal surgeries were carried out under general anesthesia without using dexmedetomine, clonidine, or ketamine. General anesthesia was induced with intravenous fentanyl (1-3mcg/mg) and propofol (1-3mg/mg), and endotracheal intubation was facilitated by intravenous cis-atracurium (0.2--0.3mg/kg) or rocuronium (0.6--0.9mg/kg). General anesthesia was maintained by sevoflurane or desflurane inhalation with intermittent bolus of cisatracurium and/or fentanyl at the discretion of the anesthesiologists. Patients receiving combined general anesthesia and regional anesthesia were excluded from analysis as well as those received regional analgesia for postoperative pain control.

Before providing ivPCA to each patient, it has been the standard practice of our acute pain service to interview the patient or his/her family. During the interview, the acute pain service team inquires and records the following histories in a standardized form regarding medical illness (including presence or absence of cardiovascular, diabetic, pulmonary, renal, liver, and gastrointestinal diseases), recreational drug usage, history of drug allergy, current cigarette or tobacco smoking status, average frequency, type (such as wine, beer, and whisky) and amount of alcohol drinking, and chronic use of analgesics or psychotropic medications. The patient's age, gender, and body weight as well as the site, type and approach (open or laparoscopy) of surgery the patient had received were also recorded in a standardized form together with the abovementioned histories. Intravenous patient-controlled analgesia (ivPCA) comprising of fentanyl or a mixture of fentanyl and morphine was provided for postoperative pain control after abdominal surgery when epidural analgesia was not adopted. Patients were instructed to use ivPCA if the intensity of pain was equal to or more than moderate on a verbal severity scale (no pain, mild pain, moderate pain, severe pain and extreme pain). Also as part of our standard practice, daily recording of cumulative opioid consumption from ivPCA was done starting postoperative day 1 in addition to the presence of opioid-related side effects including nausea, vomiting, dizziness, drowsiness, pruritus, and respiratory depression if any. If additional opioid other than from ivPCA was administered, the dosage was also recorded. These recorded data were saved as the acute pain service database.

Given multiple factors are associated with postoperative analgesic consumption \[[@pone.0171275.ref006]--[@pone.0171275.ref009]\] and occurrence of PONV \[[@pone.0171275.ref010]--[@pone.0171275.ref014]\], variables other than alcohol consumption were also included in the analysis. Candidate variables chosen for analysis included both demographic and clinical factors. Demographic factors included patients' age, gender, histories of smoking and frequent alcohol consumption. Frequent alcohol consumption is defined as having 4 or more drinks per week or drinking alcohol on 4 or more days per week. A drink is defined as 12 oz of beer, 5 oz of wine, or 1.5 oz of liquor (approximately 14g alcohol). Clinical factors included American Society of Anesthesiologist physical status, surgical type, medical histories, and drug histories regarding drug allergy and chronic use of nonsteroid anti-inflammatory drugs (NSAIDs) or psychotrophic drugs. Medical histories were categorized into pulmonary disease, diabetes mellitus (DM), cardiovascular disease, gastrointestinal diseases, liver diseases, renal diseases, and end-stage renal disease under hemodialysis. Surgical procedures were grouped into colorectal, hepatobiliary, stomach, pancreatic, urological, and splenic surgery. Surgeries scheduled as exploratory laparotomy were excluded due to great variations.

Total opioid consumption per body weight (kg) during the first two days after operation was used as the outcome measurement to evaluate the potential association between opioid consumption and candidate variables. Total opioid consumption was calculated by adding opioids administered other than from ivPCA to cumulative opioids usage from ivPCA recorded on postoperative day 2. The amount of total opioids consumed was converted to intravenous morphine equivalence using the equianalgesic conversion ratios of meperidine: morphine = 75: 10 and fentanyl: morphine = 0.1: 10 \[[@pone.0171275.ref022], [@pone.0171275.ref023]\].

Statistical analysis {#sec007}
--------------------

Categorical data were expressed in number and percentage, and continuous data were expressed in mean and standard deviation. In analyzing association between total opioid consumption and potential factors, candidate categorical factors were initially examined by two sample independent *t*-test, or analysis of variance (ANOVA). Non-parametric tests were used in case of small size in any of the categories. Candidate factors found to have some evidence (*p*\< 0.1) in the initial analyses were subsequently included in a multiple linear regression analysis.

In analyzing association between occurrence of PONV and potential factors, candidate categorical factors and continuous factors were initially examined by chi-square test and logistic regression analyses, respectively. Candidate factors found to have a *p*-value\< 0.1in the initial analyses were included in subsequent multiple logistic regression analysis. A *p*-value of \< 0.05 was considered statistically significant. All statistical analyses were performed using SPSS v17.

Results {#sec008}
=======

A total of 14,678 patients having used ivPCA for postoperative pain control between January 2010 and September 2013 were identified from the acute pain service database. Among them, 4143 patients were included in the analyses after exclusion criteria were applied and their demographic and clinical data were illustrated in [Table 1](#pone.0171275.t001){ref-type="table"}.

10.1371/journal.pone.0171275.t001

###### Demographic and clinical data of patients and univariate analysis of candidate factors potentially associated with opioid consumption after abdominal surgery.

![](pone.0171275.t001){#pone.0171275.t001g}

                                                       N (%)          Opioid consumption, mg/kg (mean ± SD)   *p*-value
  ---------------------------------------------------- -------------- --------------------------------------- -----------
  Total                                                4143(100)      1.15 ± 0.43                             
  Body weight, kg (mean ± SD)                          63.15 ±12.88                                           
  Age, years (mean ± SD)                               60.64 ±14.39                                           \< 0.001
      \< 30                                            113 (2.7)      1.34 ± 0.47                             
      30--45                                           471 (11.4)     1.33 ± 0.53                             
      45--60                                           1343 (32.4)    1.18 ± 0.43                             
      60--75                                           1532 (37.0)    1.10 ± 0.39                             
      \> 75                                            684 (16.5)     1.04 ± 0.39                             
  Gender                                                                                                      \< 0.001
      Female                                           2418 (58.4)    1.18 ± 0.44                             
      Male                                             1725 (41.6)    1.11 ± 0.42                             
  ASA                                                                                                         0.792
      1                                                76 (1.8)       1.29 ± 0.42                             
      2                                                2589 (62.5)    1.18 ± 0.44                             
      3                                                1478 (35.7)    1.10 ± 0.41                             
  Alcohol drinking                                                                                            \< 0.001
      Infrequent                                       3227 (77.9)    1.11 ± 0.40                             
      Frequent[^a^](#t001fn004){ref-type="table-fn"}   916 (22.1)     1.28 ± 0.50                             
  Current smoker                                                                                              \< 0.001
      No                                               3006 (72.6)    1.11 ± 0.41                             
      Yes                                              1137 (27.4)    1.26 ± 0.47                             
  Surgical types                                                                                              \< 0.001
      Hepatobiliary                                    1203 (29.0)    1.14 ± 0.41                             
      Colorectal                                       1673 (40.4)    1.13 ± 0.41                             
      Stomach                                          513 (12.4)     1.24 ± 0.46                             
      Pancreatic                                       210 (5.1)      1.32 ± 0.52                             
      Urological                                       504 (12.2)     1.11 ± 0.46                             
      Splenic                                          40 (1.0)       1.23 ± 0.42                             
  Medical history                                                                                             
      Pulmonary disease                                                                                       0.367
          No                                           3929 (94.8)    1.15 ± 0.43                             
          Yes                                          214 (5.2)      1.18 ± 0.50                             
      Cardiovascular disease                                                                                  \<0.001
          No                                           2343 (56.6)    1.19 ± 0.45                             
          Yes                                          1800 (43.4)    1.09 ± 0.40                             
      Diabetes mellitus                                                                                       \<0.001
          No                                           3365 (81.2)    1.16 ± 0.44                             
          Yes                                          778 (18.8)     1.10 ± 0.39                             
      Gastrointestinal disease                                                                                0.053
          No                                           3142 (75.8)    1.14 ± 0.43                             
          Yes                                          1001 (24.2)    1.17 ± 0.44                             
      Hepatic disease                                                                                         0.012
          No                                           3085 (74.5)    1.16 ± 0.44                             
          Yes                                          1058 (25.5)    1.12 ± 0.41                             
      Renal disease                                                                                           0.572
          No                                           3785 (91.4)    1.15 ± 0.43                             
          Yes                                          358 (8.6)      1.14 ± 0.42                             
      ESRD under hemodialysis                                                                                 0.859
          No                                           4062 (98.0)    1.15 ± 0.43                             
      Yes                                              81 (2.0)       1.16 ± 0.43                             
  Drug history                                                                                                
      Chronic NSAIDs user                                                                                     0.032
          No                                           4085 (98.6)    1.15 ± 0.43                             
          Yes                                          58 (1.4)       1.30 ± 0.54                             
      Chronic Psychotrophic medication                                                                        0.027
          No                                           3667 (88.5)    1.14 ± 0.42                             
          Yes                                          476 (11.5)     1.20 ± 0.51                             
      History of drug allergy                                                                                 0.305
          No                                           3658 (88.3)    1.15 ± 0.43                             
          Yes                                          485 (11.7)     1.14 ± 0.46                             

ASA: American Society of Anesthesiologist physical status

ESRD: end stage renal disease

NSAIDs: non-steroid anti-inflammatory drugs.

^a^Frequent alcohol drinking is defined as having 4 or more drinks per week or drinking alcohol on 4 or more days per week. A drink is defined as 12 oz of beer, 5 oz of wine, or 1.5 oz of liquor (approximately 14g alcohol)

Factors associated with increased postoperative opioid consumption {#sec009}
------------------------------------------------------------------

Univariate analyses revealed that male gender, frequent alcohol drinking, current smoker, certain surgical types, chronic use of NSAIDs, chronic use of psychotrophic medications, and gastrointestinal diseases were associated with increased opioid consumption. On the other hand, cardiovascular diseases, diabetes mellitus and hepatic diseases were associated with decreased opioid consumption ([Table 1](#pone.0171275.t001){ref-type="table"}). Age was inversely related to the total opioid consumption. Subsequent multiple regression analysis revealed that young age, frequent alcohol drinking, positive smoking status, stomach or pancreatic surgery and chronic use of NSAIDs or psychotrophic medications were associated with increased opioid consumption, while cardiovascular and hepatic disease were associated with decreased opioid consumptions ([Table 2](#pone.0171275.t002){ref-type="table"}).

10.1371/journal.pone.0171275.t002

###### Multiple regression analysis of opioid consumption after abdominal surgery.

![](pone.0171275.t002){#pone.0171275.t002g}

                                                                    Estimate (mg/kg)   95% CI             *p*-value
  ----------------------------------------------------------------- ------------------ ------------------ -----------
  Age                                                               -0.005             -0.006 to -0.005   \<0.001
  Female                                                            -0.006             -0.036 to 0.023    0.669
  Frequent alcohol drinking[^a^](#t002fn002){ref-type="table-fn"}   0.117              0.082 to 0.151     \<0.001
  Current smoker                                                    0.082              0.048 to 0.115     \<0.001
  Surgical types                                                                                          
      Hepatobiliary                                                 0                                     
      Colorectal                                                    0.008              -0.026 to 0.042    0.641
      Stomach                                                       0.108              0.062 to 0.153     \<0.001
      Pancreatic                                                    0.187              0.125 to 0.248     \<0.001
      Urological                                                    -0.024             -0.069 to 0.021    0.288
      Splenic                                                       0.100              -0.029 to 0.230    0.129
  Cardiovascular disease                                            -0.031             -0.059 to -0.003   0.031
  Diabetes Mellitus                                                 -0.020             -0.053 to 0.014    0.252
  Gastrointestinal disease                                          0.029              -0.001 to 0.058    0.060
  Hepatic disease                                                   -0.043             -0.076 to -0.011   0.009
  Chronic use of NSAIDs                                             0.112              0.005 to 0.219     0.040
  Chronic use of psychotrophic medications                          0.087              0.047 to 0.127     \<0.001

NSAIDs: non-steroid anti-inflammatory drugs.

^a^Frequent alcohol drinking is defined as having 4 or more drinks per week or drinking alcohol on 4 or more days per week. A drink is defined as 12 oz of beer, 5 oz of wine, or 1.5 oz of liquor (approximately 14g alcohol)

Factors associated with postoperative nausea {#sec010}
--------------------------------------------

Univariate analysis revealed that young age, female gender, urological surgery, and a history of drug allergy were associated with increased risks of postoperative nausea, while frequent alcohol drinking, current smoker, stomach surgery, cardiovascular and hepatic disease were associated with decreased risks of postoperative nausea ([Table 3](#pone.0171275.t003){ref-type="table"}). Subsequent multiple logistic regression analysis revealed that female gender was associated with increased risks of postoperative nausea while frequent alcohol drinking and stomach surgery were associated with decreased risks of postoperative nausea ([Table 4](#pone.0171275.t004){ref-type="table"}).

10.1371/journal.pone.0171275.t003

###### Univariate analysis of candidate factors potentially associated with occurrence of nausea after abdominal surgery.
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                                                       Odds ratio   95% CI         *p*-value
  ---------------------------------------------------- ------------ -------------- -----------
  Age, years                                           0.99         0.99 to 1.00   0.026
  Gender                                                                           
      Male                                             1                           
      Female                                           2.70         2.23 to 3.27   \<0.001
  Alcohol drinking                                                                 
      Frequent[^a^](#t003fn004){ref-type="table-fn"}   0.39         0.29 to 0.52   \<0.001
      Infrequent                                       1                           
  Current smoker                                                                   
      Yes                                              0.51         0.40 to 0.65   \<0.001
      No                                               1                           
  Surgical types                                                                   
      Hepatobiliary                                    1                           
      Colorectal                                       1.14         0.91 to 1.43   0.253
      Stomach                                          0.60         0.41 to 0.88   0.008
      Pancreatic                                       0.79         0.48 to 1.30   0.358
      Urological                                       1.55         1.16 to 2.08   0.003
      Splenic                                          1.08         0.42 to 2.79   0.879
  Medical history                                                                  
      Pulmonary disease                                                            
          Yes                                          0.81         0.51 to 1.27   0.356
          No                                           1                           
      Cardiovascular disease                                                       
          Yes                                          0.80         0.66 to 0.96   0.019
          No                                           1                           
      Diabetes mellitus                                                            
          Yes                                          0.86         0.67 to 1.10   0.239
          No                                           1                           
      Gastrointestinal disease                                                     
          Yes                                          0.85         0.68 to 1.06   0.146
          No                                           1                           
      Hepatic disease                                                              
          Yes                                          0.76         0.61 to 0.95   0.016
          No                                           1                           
      Renal disease                                                                
          Yes                                          1.00         0.72 to 1.39   0.994
          No                                           1                           
      ESRD under hemodialysis                                                      
          Yes                                          0.78         0.37 to 1.62   0.503
          No                                           1                           
  Drug history                                                                     
      Chronic NSAIDs user                                                          
          Yes                                          0.39         0.12 to 1.24   0.109
          No                                           1                           
      Chronic Psychotrophic medication                                             
          Yes                                          0.94         0.70 to 1.27   0.690
          No                                           1                           
      History of drug allergy                                                      
          Yes                                          1.54         1.19 to 1.99   0.001
          Never                                        1                           

ASA: American Society of Anesthesiologist physical status

ESRD: end stage renal disease

NSAIDs: non-steroid anti-inflammatory drugs.

^a^Frequent alcohol drinking is defined as having 4 or more drinks per week or drinking alcohol on 4 or more days per week. A drink is defined as 12 oz of beer, 5 oz of wine, or 1.5 oz of liquor (approximately 14g alcohol)

10.1371/journal.pone.0171275.t004

###### Multiple logistic regression analysis of occurrence of nausea after abdominal surgery.
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                                                                    Odds ratio   95% CI         *p*-value
  ----------------------------------------------------------------- ------------ -------------- -----------
  Age                                                               1.00         0.99 to 1.00   0.245
  Female                                                            2.19         1.75 to 2.74   \<0.001
  Frequent alcohol drinking[^a^](#t004fn001){ref-type="table-fn"}   0.59         1.18 to 2.28   0.003
  Current smoker                                                    0.93         0.70 to 1.25   0.644
  No Cardiovascular disease                                         1.02         0.74 to 1.41   0.916
  No Hepatic disease                                                1.23         0.89 to 1.70   0.212
  History of drug allergy                                           2.56         0.79 to 8.30   0.118
  Surgical types                                                                                
      Hepatobiliary                                                 1                           
      Colorectal                                                    0.99         0.77 to 1.28   0.962
      Stomach                                                       0.56         0.38 to 0.83   0.004
      Pancreatic                                                    0.66         0.40 to 1.10   0.110
      Urological                                                    1.31         0.96 to 1.79   0.092
      Splenic                                                       0.74         0.28 to 1.95   0.543

^a^Frequent alcohol drinking is defined as having 4 or more drinks per week or drinking alcohol on 4 or more days per week. A drink is defined as 12 oz of beer, 5 oz of wine, or 1.5 oz of liquor (approximately 14g alcohol).

Factors associated with postoperative vomiting {#sec011}
----------------------------------------------

Univariate analysis revealed that female gender and urological surgery were associated with increased risks of postoperative vomiting, while frequent alcohol drinking, current smoker and stomach surgery were associated with decreased risks of postoperative vomiting ([Table 5](#pone.0171275.t005){ref-type="table"}). Subsequent multiple logistic regression analysis revealed that female gender and urological surgery were associated with increased risks of postoperative vomiting, while frequent alcohol drinking and stomach surgery were associated with decreased risks of postoperative vomiting ([Table 6](#pone.0171275.t006){ref-type="table"}).

10.1371/journal.pone.0171275.t005

###### Univariate analysis of candidate factors potentially associated with occurrence of vomiting after abdominal surgery.
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                                                       Odds ratio   95% CI         *p*-value
  ---------------------------------------------------- ------------ -------------- -----------
  Age, years                                           0.99         0.98 to 1.00   0.113
  Sex                                                                              
      Male                                             1                           
      Female                                           3.88         2.79 to 5.40   \<0.001
  Alcohol drinking                                                                 
      Frequent[^a^](#t005fn004){ref-type="table-fn"}   0.26         0.15 to 0.45   \<0.001
      Infrequent                                       1                           
  Current smoker                                                                   
      Yes                                              0.42         0.28 to 0.64   \<0.001
      No                                               1                           
  Surgical types                                                                   
      Hepatobiliary                                    1                           
      Colorectal                                       1.07         0.73 to 1.55   0.735
      Stomach                                          0.48         0.24 to 0.95   0.036
      Pancreatic                                       0.71         0.30 to 1.68   0.433
      Urological                                       2.48         1.63 to 3.76   \<0.001
      Splenic                                          1.27         0.30 to 5.41   0.749
  Medical history                                                                  
      Pulmonary disease                                                            
          Yes                                          1.18         0.63 to 2.20   0.609
          No                                           1                           
      Cardiovascular disease                                                       
          Yes                                          0.87         0.64 to 1.18   0.366
          No                                           1                           
      Diabetes mellitus                                                            
          Yes                                          0.91         0.61 to 1.34   0.624
          No                                           1                           
      Gastrointestinal disease                                                     
          Yes                                          0.76         0.52 to 1.09   0.138
          No                                           1                           
          Hepatic disease                                                          
          Yes                                          0.72         0.50 to 1.05   0.086
          No                                           1                           
      Renal disease                                                                
          Yes                                          1.08         0.65 to 1.80   0.766
          No                                           1                           
      ESRD under hemodialysis                                                      
          Yes                                          1.75         0.75 to 4.07   0.196
          No                                           1                           
  Drug history                                                                     
      Chronic NSAIDs user                                                          
          Yes                                          1.18         0.36 to 3.80   0.785
          No                                           1                           
      Chronic Psychotrophic medication                                             
          Yes                                          1.05         0.66 to 1.65   0.845
          No                                           1                           
      History of drug allergy                                                      
          Yes                                          1.14         0.73 to 1.77   0.562
          Never                                        1                           

ASA: American Society of Anesthesiologist physical status

ESRD: end stage renal disease

NSAIDs: non-steroid anti-inflammatory drugs.

^a^Frequent alcohol drinking is defined as having 4 or more drinks per week or drinking alcohol on 4 or more days per week. A drink is defined as 12 oz of beer, 5 oz of wine, or 1.5 oz of liquor (approximately 14g alcohol).

10.1371/journal.pone.0171275.t006

###### Multiple logistic regression analysis of occurrence of vomiting after abdominal surgery.
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                                                                    Odds ratio   95% CI         *p*-value
  ----------------------------------------------------------------- ------------ -------------- -----------
  Female                                                            3.13         2.14 to 4.58   \<0.001
  Frequent alcohol drinking[^a^](#t006fn001){ref-type="table-fn"}   0.49         1.09 to 3.84   0.026
  Current smoker                                                    1.01         0.62 to 1.66   0.961
  Surgical types                                                                                
      Hepatobiliary                                                 1                           
      Colorectal                                                    0.93         0.64 to 1.36   0.701
      Stomach                                                       0.46         0.23 to 0.92   0.028
      Pancreatic                                                    0.59         0.25 to 1.40   0.231
      Urological                                                    2.05         1.34 to 3.14   \<0.001
      Splenic                                                       0.90         0.21 to 3.86   0.883

^a^Frequent alcohol drinking is defined as having 4 or more drinks per week or drinking alcohol on 4 or more days per week. A drink is defined as 12 oz of beer

5 oz of wine, or 1.5 oz of liquor (approximately 14g alcohol).

Discussion {#sec012}
==========

Similar to previous reports, our current analyses have revealed that young age, smoking, and upper abdominal surgeries (stomach and pancreatic surgeries) as significant predictors of increased opioid consumption for postoperative pain control \[[@pone.0171275.ref006]--[@pone.0171275.ref009]\]. In addition, our current analyses further identified frequent alcohol drinking as a significant predictor of postoperative opioid consumption. The exact mechanisms underlying the association between frequent alcohol drinking and increased postoperative opioid consumption are unclear. In animal experiments, chronic alcohol consumption was associated with mu-opioid receptors dysfunction in the spinal cord \[[@pone.0171275.ref020]\] and produced tolerance to opioid antinociception through inhibition of mu-opioid receptor endocytosis \[[@pone.0171275.ref021]\]. Therefore, it is likely that the increased opioid consumption for postoperative pain control in frequent alcohol drinkers might result from alcohol-induced tolerance to opioid analgesic effect. The mechanisms underlying alcohol-induced tolerance to opioid analgesic effect remain unknown. In a recent review, robust evidence has been provided to demonstrate that chronic alcohol drinking activates the N-methyl-D-aspartate receptor (NMDAR) signaling and enhances synaptic plasticity in the brain, which greatly contributes to the alcohol-related behaviors \[[@pone.0171275.ref024]\]. Altered NMDAR activity has also been observed in the spinal cord after chronic alcohol exposure \[[@pone.0171275.ref025]\]. Given that enhanced activity of NMDAR also plays a pivotal role in the development of morphine tolerance induced by repeated morphine administration \[[@pone.0171275.ref026]\], it is highly likely that chronic alcohol consumption produced tolerance to opioid analgesic effects through activating NMDAR signaling in the central nervous system. Further research on the role of NMDAR signaling in the development of alcohol-induced tolerance to opioid analgesic effect is warranted.

In agreement with previous studies, our analyses have identified female gender \[[@pone.0171275.ref010]--[@pone.0171275.ref014]\] and urological surgery \[[@pone.0171275.ref012]\] as risk factors of PONV. In addition, our analyses suggested that frequent alcohol drinking may be protective against PONV. Similar result on postoperative nausea was reported previously \[[@pone.0171275.ref020]\]. The mechanisms underlying PONV were not clearly understood. Based on clinical studies, the use of volatile anesthetics may be the main cause of PONV in the early (2--6 hours) postoperative period, while postoperative opioids may account for PONV in the delayed postoperative period \[[@pone.0171275.ref013], [@pone.0171275.ref014]\]. Since only PONV occurred in POD1 and POD2 (delayed postoperative period) were recorded and analyzed in this current study, it is likely that frequent alcohol drinking could exert a protective effect against opioid-induced nausea and vomiting. Contrary to previous reports \[[@pone.0171275.ref010]--[@pone.0171275.ref011]\], current smoking status is not associated with a lower risk of PONV in our analyses. Similar result has been reported in recent studies \[[@pone.0171275.ref027], [@pone.0171275.ref028]\]. The reason of this discrepancy is unknown.

Our study also revealed other predicting factors of postoperative opioid consumption that were not previously reported. Among these factors, pancreatic surgery was associated with the most prominent effect on postoperative opioid consumption. This may be related to the large surgical wound and profound tissue injury associated with pancreatic surgery. Although the association between cardiovascular and hepatic diseases with postoperative opioid consumption was statistically significant, their clinical significance seemed negligible when considering their small estimate effects (0.03 and0.04 mg/kg morphine in 2 days).

In current analyses, the occurrence of PONV was less frequent after stomach surgery. Mu opioid receptors have been identified on nerve terminals in myenteric plexus of the stomach \[[@pone.0171275.ref029]\]. It is possible that the removal of these peripheral opioid receptors during gastrectomy contributed to the decreased occurrence of PONV after stomach surgery. Further study is required to investigate this hypothesis.

Our analyses have several limitations. First, although collecting information regarding the frequency and amount of alcohol consumption was mandatory before instituting the ivPCA for each patient, we did not specifically collect information regarding the duration of such drinking behavior as well as blood level of alcohol. Therefore, the cumulating alcohol exposure could not be estimated. In addition, we categorized alcohol consumption into dichotomous variables as frequent and infrequent alcohol drinking, precluding a precise measurement of alcohol consumption (e.g., amount, frequency) in relation to opioid consumption for postoperative pain control. Hence, we could not quantitatively determine the minimal duration, frequency, or amount of alcohol consumption required to produce tolerance to opioid analgesic effects or opioid-related PONV in humans. In rats, tolerance to opioid antinociception developed after 8 weeks, but not 4 weeks, of alcohol consumption \[[@pone.0171275.ref021]\] and persisted up to 24 days after alcohol withdrawal \[[@pone.0171275.ref020]\]. Second, psychological distress was reported as a significant predictor of postoperative analgesic consumption \[[@pone.0171275.ref006]\], but preoperative psychological evaluation was not available in our analyses. However, a history of chronic use of psychotropic medication might serve as a surrogate indicator of psychological distress. Indeed, in line with previous report, our analyses showed positive association between chronic use of psychotropic medications and increased opioid consumption. Third, pharmacogenetic analyses were not performed; the genetic factors might impact on postoperative opioid requirement \[[@pone.0171275.ref007], [@pone.0171275.ref008]\]. Fourth, histories regarding motion sickness and PONV, two well-recognized risk factors of PONV, were not available in our reviewed medical records and therefore were not included in our analyses. Fifth, we did not include intraoperative opioid doses as a potential factor in the analysis, which, in high doses, have been associated with increased postoperative morphine consumption \[[@pone.0171275.ref030]\]. However, the impact of intraoperative opioids on postoperative opioid consumption is still controversial \[[@pone.0171275.ref031]\] and if exists, seems to be limited to remifentanil and cannot to be extrapolated to other opioids such as fentanyl and sufentanil \[[@pone.0171275.ref030]\]. Since only fentanyl was used intraoperatively and remifentanil was not available in our institution, we assume that not including intraoperative opioids in our current analysis might not have significant impact on the result regarding postoperative opioid consumption. Similarly, in a recent meta-analysis, intraoperative opioid is not an independent predictor of PONV \[[@pone.0171275.ref011]\]. Therefore, not including intraoperative opioids in our analysis might not impact the result regarding occurrence of PONV. Finally, the duration of operation, invasiveness of specific operative methods, degree of postoperative alertness, postoperative admission to ward or intensive care unit (ICU), length of ICU stay, duration of mechanical ventilation, and timing of extubation may also impact the postoperative opioid consumption and PONV but were not included in the analysis.

In conclusion, frequent alcohol drinkers consumed an increased amount of opioids for postoperative pain control but were less likely to suffer from PONV. Frequent alcohol drinking possibly produced tolerance to both opioid analgesic effect and opioid-related nausea and vomiting. Further prospective studies are required to exam this hypothesis.
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